257 related articles for article (PubMed ID: 4054232)
1. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
Gnessi L; Ruff MR; Fraioli F; Pert CB
Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the presence of specific receptors for N-formyl chemotactic peptides on human spermatozoa.
Gnessi L; Fabbri A; Silvestroni L; Moretti C; Fraioli F; Pert CB; Isidori A
J Clin Endocrinol Metab; 1986 Oct; 63(4):841-6. PubMed ID: 3018025
[TBL] [Abstract][Full Text] [Related]
3. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
Rot A; Henderson LE; Copeland TD; Leonard EJ
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
[TBL] [Abstract][Full Text] [Related]
4. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
Bonora GM; Toniolo C; Freer RJ; Becker EL
Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
[TBL] [Abstract][Full Text] [Related]
5. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
Donabedian H; Gallin JI
J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
7. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
Harvath L; Aksamit RR
J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
[TBL] [Abstract][Full Text] [Related]
8. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Showell HJ; Freer RJ; Becker EL
J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
[TBL] [Abstract][Full Text] [Related]
9. C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor.
Dalpiaz A; Ferretti ME; Vertuani G; Traniello S; Scatturin A; Spisani S
Eur J Pharmacol; 2002 Feb; 436(3):187-96. PubMed ID: 11858798
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Fantone JC; Freer RJ; Ward PA
Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
[TBL] [Abstract][Full Text] [Related]
11. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
[TBL] [Abstract][Full Text] [Related]
12. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
Rotrosen D; Malech HL; Gallin JI
J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
[TBL] [Abstract][Full Text] [Related]
13. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
14. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat.
Bautista AP; Elliott KE
Life Sci; 1994; 54(11):721-30. PubMed ID: 8107522
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of binding of a potent chemotactic formyl tetrapeptide, formylmethionyl-leucyl-phenylalanyl-phenylalanine, to the receptors on rabbit neutrophils.
Kermode JC; Muthukumaraswamy N; Freer RJ
J Leukoc Biol; 1988 May; 43(5):420-8. PubMed ID: 2836540
[TBL] [Abstract][Full Text] [Related]
16. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
17. [Acylated tripeptides as chemotaxin antagonists (author's transl)].
Opitz W; Fruchtmann R
Hoppe Seylers Z Physiol Chem; 1981 Aug; 362(8):1037-41. PubMed ID: 7346374
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of fMLP pocket dimensions and features using formyltetrapeptides.
Cavicchioni G; Varani K; Niccoli S; Rizzuti O; Spisani S
J Pept Res; 1999 Oct; 54(4):336-43. PubMed ID: 10532239
[TBL] [Abstract][Full Text] [Related]
19. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
